Diagnosis: Herpes zoster (shingles)
A 65-year-old male presents with a 3-day history of painful grouped vesicles localized to the right thoracic dermatome. The patient reports significant burning pain and itching, with vesicular lesions evolving from erythematous macules, consistent with a viral etiology. This case illustrates the classic presentation of a common condition caused by reactivation of varicella-zoster virus.
A 65-year-old male presents with a 3-day history of painful grouped vesicles localized to the right thoracic dermatome. The patient reports significant burning pain and itching, with vesicular lesions evolving from erythematous macules. Examination reveals:Grouped vesicles: Clusters of vesicles on an erythematous base.Dermatomal distribution: Lesions confined to the right T4-T6 dermatomes.Associated pain: Severe, burning pain in the affected area.Constitutional symptoms: Mild fever and malaise noted.Neurological examination: No motor deficits or sensory loss.
The patient reports that the symptoms began with localized pain 2 days prior to the appearance of the vesicular rash. He notes a recent episode of significant stress and had a mild upper respiratory infection a few weeks ago. The patient has a past medical history of hypertension and is otherwise healthy. He has no known history of immunosuppression or prior episodes of herpes zoster. Family history is non-contributory. Socially, he is retired and lives alone, with no recent travel history.Onset: Symptoms began with pain followed by vesicular rash.Triggers: Recent stress and mild upper respiratory infection.Past medical history: Hypertension, no known immunosuppression.Social history: Retired, lives alone, no recent travel.No prior treatments: No antiviral therapy or vaccination history.
Acute / First-Line ManagementAntiviral therapy: Initiate Acyclovir 800 mg orally five times daily for 7 days, or consider Valacyclovir 1 g orally three times daily for 7 days for improved bioavailability.Pain management: Acetaminophen or NSAIDs for mild pain; consider opioids for severe pain.Topical treatments: Calamine lotion or lidocaine patches may provide symptomatic relief.Workup and Diagnostic ConfirmationClinical diagnosis: Based on characteristic presentation; laboratory testing typically not required unless atypical.Viral PCR: Consider in atypical cases or immunocompromised patients.Serology: Varicella-zoster virus IgG can confirm previous infection but is not needed for acute diagnosis.Long-Term ManagementPostherpetic neuralgia prevention: Consider gabapentin or pregabalin if pain persists beyond acute phase.Vaccination: Recommend Shingrix vaccination for future prevention in patients over 50 years old.Follow-up: Schedule follow-up to monitor pain management and any complications.
Herpes simplex virus (HSV) infection: Typically presents with grouped vesicles but often involves the lips or genital area; consider prior history of oral or genital lesions.Contact dermatitis: May present with vesicles but usually has an identifiable allergen or irritant; distribution may be more widespread and not dermatomal.Impetigo: Bacterial infection leading to vesicles, often crusting; typically occurs in children and lacks dermatomal distribution.Scabies: Can cause vesicular lesions, particularly in the web spaces; pruritus is often more generalized.Dermatitis herpetiformis: Presents with vesicles but is associated with gluten sensitivity and typically has a different distribution.Localized cutaneous candidiasis: May present with vesicular lesions, but these are usually in intertriginous areas and associated with pruritus.Shingles vaccine-related rash: Can occur post-vaccination; however, the clinical features differ from a typical shingles outbreak.Viral exanthems: Various viral infections may present with vesicular lesions, but systemic symptoms and distribution will differ.
High-Yield PearlsClassic presentation: Herpes zoster typically presents with a unilateral, dermatomal vesicular rash accompanied by significant pain.Timing of treatment: Early initiation of antiviral therapy within 72 hours of rash onset significantly reduces the risk of complications.Postherpetic neuralgia: A common complication that can be debilitating; early pain management is essential in preventing this condition.Vaccination: The Shingrix vaccine is recommended for adults over 50 to prevent herpes zoster and its complications.Stress and illness: Reactivation of varicella-zoster virus can be triggered by stress or illness, underscoring the need for awareness in at-risk populations.Recognizing the classic presentation of herpes zoster is crucial for timely intervention and prevention of complications.
Tags: herpes zoster, shingles, VZV